Search CORE

8 research outputs found

Successful strategy to improve the specificity of electronic statin–drug interaction alerts

Author: A Asberg
A Asberg
A Thibault
AJ Busti
AL Mazzu
B Hsiang
BJ Ring
C Chen
C Kyrklund
C Kyrklund
C Kyrklund
C Kyrklund
C Olbricht
Caroline Henrike Storch
Christian Senger
D Schmassmann-Suhijar
DW Schneck
Fichtenbaum CJ Gerber JG, Rosenkranz SL, Segal Y, Aberg JA, Blaschke T, et al, NIAID AIDS Clinical Trials Group
GJ Kuperman
GW Amsden
H Sijs van der
H Watanabe
Hanna Marita Seidling
Holdaas H Felström B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al, on behalf of the assessment of LEscol in renal transplantation (ALERT) study investigators
Ingeborg Walter-Sack
J Dingemanse
J Kirchheiner
JA Aberg
JA Kobashigawa
JA Tobert
Jens Kaltschmidt
JG Gerber
JJ Kiser
JT Backman
JT Backman
JT Backman
JW Park
JW Park
KJ Cooper
KJ Cooper
KT Kivistö
L Becquemont
L Gullestad
M Arnadottir
M Hermann
M Ucar
MA Omar
MB Regazzi
MD Paterno
N Ichimaru
NE Azie
O Mousa
PH Hsyu
PH Siedlik
PJ Neuvonen
PJ Neuvonen
R Goldberg
R Imamura
RJ Höppener
S Nishio
SG O'Brien
SG Simonson
T Kantola
T Kantola
T Kantola
TA Jacobson
Thilo Bertsche
V Launay-Vachar
Walter Emil Haefeli
WE Haefeli
WP Lemahieu
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein

Author: Azie NE
Bensoussan C
Chaffman M
Gorski JC
Hostetler KA
Jones DR
Lown KS
Lowry OH
Mayhew BS
Olkkola KT
Palkama VJ
Pichard L
Sutton D
Thomas AR
Tinel M
Varhe A
Watkins PB
Watkins PB
Wrighton SA
Publication venue: Blackwell Science Inc
Publication date
Field of study

Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes

Author: A Tracqui
AC Nelson
C Iribarne
D Brewster
D Pessayre
DE Moody
DE Moody
DJ Newton
G Fischer
J Boyd
JW Lewis
K Ohyama
KK Khan
KR Yeo
LC Wienkers
M Sekar
ML Schrag
NE Azie
OH Lowry
P Kintz
PE Nolan
PN Gueye
RB Ibrahim
SL Walsh
T Kantola
T Kilicarslan
TS Maurer
W Ling
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins

Author: AHMAD S
AYANIAN JZ
AZIE NE
BALLANTYNE CM
BATES DW
BIESENBACH G
Chad R Worz
CORPIER CL
CUPP MJ
DECOULX E
EVERETT DW
HATANAKA T
HORN M
HORSMANS Y
JACOBSON RH
KANTOLA T
KEOGH A
KYRKLUND C
LAZAROU J
LEES RS
LENNERNAS H
Michael Bottorff
MICHALETS EL
MUCK W
NEUVONEN PJ
NEUVONEN PJ
NORMAN DJ
PERAULT MC
RAGAZZI MB
ROSENBERG AD
SCHMASSMANN-SUHIJAR D
SEGAERT MF
SPACH DH
TRANSON C
TRILLI LE
US FOOD AND DRUG ADMINISTRATION
VEERKAMP JH
Publication venue: 'Informa Healthcare'
Publication date
Field of study

Adherence to Drug Label Recommendations for Avoiding Drug Interactions Causing Statin-Induced Myopathy–A Nationwide Register Study

Author: A Bakhai
A Heerey
AE Ratz Bravo
AJ Bergman
B Mannheimer
B Mannheimer
B Wettermark
Birgit Eiermann
Buster Mannheimer
C Kyrklund
C Kyrklund
DW Schneck
EE Ming
Giuseppe Biondi-Zoccai
GW Amsden
H Lennernas
HM Devold
HS Lau
J Armitage
JD Spence
Jennifer Settergren
JT Backman
JT Backman
KJ Cooper
KJ Ronaldson
KT Kivisto
L Bjerrum
LE Gustavson
M Eliasson
M Katoh
M Law
MB Bottorff
MD Ahearn
MJ Cziraky
NE Azie
O Mousa
PA Glassman
PA Glassman
PD Martin
PH Jones
PH Siedlik
PJ Neuvonen
PJ Neuvonen
S Nishio
S Saivin
S Schech
SS Egger
T Kantola
T Kantola
TA Jacobson
WJ Pan
Y Bottiger
Publication venue: 'Public Library of Science (PLoS)'
Publication date
Field of study

A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan

The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspective

Author: A Suzuki
AH Kadish
AJ Moss
AS Hollister
B Charbit
B Eckert
BD Anson
BD Brown
BF McBride
BN Singh
C Chouabe
C Nau
C Pratt
CA Karle
CP Lau
D Katritsis
D Shaffer
DM Roden
E Carbone
E Eden
E Ficker
E Guatteo
EP Harrigan
F Badilini
F Sesti
GA Gamouras
GA Gintant
GB Gurrola
GE Kirsch
GJ Noel
GJ Noel
H Yildirim
HA Hassaballa
HJ Witchel
J Kang
J Morganroth
J-P Couderc
JC Lin
JL Bauman
JL Mortara
JM Nasir
JT Barbey
K Titier
KC Oberg
KJ Totterman
KR Lawrence
M Malik
M Malik
M Malik
M Prabhakar
M Schlepper
M Varterasian
MA Rezkalla
MC Granberry
MC Sanguinetti
MJ Ackerman
MJ Ackerman
MJ Krantz
ML Bruin De
MM Bednar
MM Cooney
MR Bedigian
MR Carnethon
N Abi-Gerges
NE Azie
PB Iannini
PJ Gandhi
PL Bonate
R Frothingham
RC Owens Jr
RE Berger
RR Fenichel
RR Shah
RR Shah
RR Shah
RT Robinson
S Lee
S Luo
S Miyamoto
S Shibata
SG Priori
SK Daya
TA Kuusela
TW Koh
V Kuhlkamp
VF Mauro
W Haverkamp
W Herron
WA Ray
WS Redfern
YA Kuryshev
YA Kuryshev
YG Yap
Z Zhou
Publication venue: 'SAGE Publications'
Publication date
Field of study

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

Author: -et al. Etherton T
Abate N
Abshagen U
Agardh CD
Aker S
Akgun S
Alvarez C
American Diabetes Association.
Anderson P
Anonymous.
Anonymous.
Antikainen M
Aranda Arcas JL
Arnadottir M
Arnadottir M
Asberg A
Assmann G
Aufenanger J
Avogaro P
Azie NE
Barbir M
Bennett WM
Best JD
Biesenbach G
Block GA
Boissonnat P
Borchhardt K
Bostom AG
Brown JH
Bruce R
Castaneda C
Chen HH
Chertow GM
Chicaud P
Coggins CH
Colletti RB
Connelly PW
Couture P
Curtis JJ
de Lorgeril M
Desager JP
Dick TB
Dillon IJ.
Dominguez-Munoz JE
Ducloux D
Enos WF
Evans JR
Figueroa O
Flynn WJ
Foley RN
Friedewald WT
Gall M-A
Gallin JI
Ganesh SK
Ghanem H
Glueck CJ
Gokal R
Goldberg AP
Goldberg RB
Goldstein LB
Goldstein S
Gonyea JE
Gore JM
Gylling H
Hallikainen MA
Halstenson CE
Hausberg M
Hilbrands LB
Hirai M
Hollander AA
Hommel E
Hottelart C
Hricik DE
Hunsicker LG
Ingulli E
Jarvisalo MJ
Jensen RA
John GT
Johnson C
Joven J
Jungers P
Kantola T
Kantola T
Kantola T
Kasiske BL
Kasiske BL
Kasiske BL
Kasiske BL
Kasiske BL
Kaysen GA
Keilani T
Keogh A
Klein R
Kliem V
Knauf H
Knipscheer HC
Knipscheer HC
Krauss RM
Kupin W
Kwiterovich PO
Kwiterovich PO
Lageder H.
Lambert M
Lawson ML
Lesne M
Levey AS
Lifton L
Lilja JJ
Lilja JJ
Lin JC
Lipscombe J
Luoma PV
Maachi K
Macmahon M
Marth E
Martinez Hernandez BE
Massy ZA
Massy ZA
Mccrindle BW
Mcgill HC
Mendez I
Merk W
Mertz DP
Milliner DS
Moore R
Mosca L
Mourad G
Moustapha A
MRC/BHF
Muck W
Muller P
Nakai A
National Kidney Foundation Kidney.
National Kidney Foundation.
National Kidney Foundation.
Nauck M
Neuvonen PJ
Neuvonen PJ
Nielsen S
NIH Consensus Development Panel on Physical Activity and Cardiovascular Health.
Niinikoski H
Niinikoski H
Niinikoski H
Nishimura M
Nutrition Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/Doqi).
O'Brien T
Olbricht C
Olson RE.
Olsson AG
Ong CS
Papacostas S.
Park JW
Pyorala K
Querfeld U
Querin S
Rakotoambinina B
Ravid M
Rayner BL
Roodnat JI
Rossner S
Rouffy J
Ryder REJ
Sacks FM
Samuelsson O
Sanjad SA
Scanferla F
Schlierf G
Schwarz KB
Seidel D.
Senti M
Siedlik PH
Singh A
Smith SC
Spratt P
Stefanutti C
Steiner G.
Stern RH
Tangrea JA
Taskinen MR
Teruel JL
The Lipid Research Clinics Program Epidemiology Committee.
the Long-term Intervention with Pravastatin in Ischaemic Disease (Lipid) Study Group.
The Tobacco Use and Dependence Clinical Practice Guideline Panel Staff, and Consortium Representatives.
Thomas ME
Ticho BS
Tonolo G
Toth T
Tsimihodimos V
U.S. Preventive Services Task Force.
UK Prospective Diabetes Study Group.
United States Renal Data System.
Urakaze M
van den Dorpel MA
van der Schaaf MR
Van Gool S
van Stiphout WA
Velosa JA
Verges BL.
Verrotti A
Vierhapper H
Viikari J
Walker WG.
Warwick GL
Webb OL
Wen X
Wenger NK.
West RJ
Wheeler KA
Williams AJ
Williams CL
Yeun JY
Publication venue: 'Wiley'
Publication date
Field of study

core

core